Hao Tian Development Group Limited provided earnings guidance for the year ended March 31, 2015. For the year, the company expected to record a net profit as compared to the net loss for the corresponding period in 2014. The improvement of the group's results was mainly attributable to, among other things, realised gains of approximately HKD 154 million from securities investment; and fair value gains of approximately HKD 1.9 billion from investment comprising listed equity securities held for trading.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.141 HKD | -.--% | -4.73% | +25.89% |
02-23 | Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director | CI |
2023 | Aceso Life Science's Loss Widens in Fiscal H1 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.89% | 133M | |
+6.21% | 10.19B | |
+2.53% | 7.1B | |
+6.24% | 4.29B | |
-19.46% | 1.73B | |
+2.44% | 496M | |
-34.83% | 414M | |
-13.05% | 412M | |
+12.56% | 314M | |
-20.28% | 266M |
- Stock Market
- Equities
- 474 Stock
- News Aceso Life Science Group Limited
- Hao Tian Development Group Limited Provides Earnings Guidance for the Year Ended March 31, 2015